Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2015

Dec 16, 2015

30786_dirs_2015-12-15_eaa35ea5-b51d-46ef-a29c-c1d74098cc05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-12-14

Reporting Person: SODERBERG SHAWN MARIE (EVP, General Counsel, Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-14 Bio-Rad A Common Stock M 1300 $122.36 Acquired 1952.1164 Direct
2015-12-14 Bio-Rad A Common Stock S 1300 $135.50 Disposed 652.1164 Direct
2015-12-14 Bio-Rad A Common Stock M 600 $119.54 Acquired 1252.1164 Direct
2015-12-14 Bio-Rad A Common Stock S 600 $135.50 Disposed 652.1164 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-14 Non-Qualified Stock Option (right to buy) $122.36 M 1300 Disposed 2023-12-02 Bio-Rad A Common Stock (1300) Direct
2015-12-14 Non-Qualified Stock Option (right to buy) $119.54 M 600 Disposed 2024-09-10 Bio-Rad A Common Stock (600) Direct

Footnotes

F1: The option became exercisable in five equal annual installments beginning on December 2, 2014, which was the first anniversary of the date on which the option was granted.

F2: The option became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted.